STEL heads into its May 1 earnings event with the numbers already on the table — and they cleared the bar.
The company reported Q1 adjusted EPS of $0.58 against a $0.51 estimate, a beat of roughly 14%. Revenue of $111 million also topped the $108 million consensus. The previous two earnings prints produced a 1.5% one-day gain and a 6.2% five-day gain each, suggesting the stock has rewarded beats with measured follow-through rather than sharp moves.
The more pressing storyline is not the earnings themselves but the merger. Prosperity Bancshares received regulatory approval to acquire Stellar on April 22. That clearance removed a major uncertainty for shareholders, and it explains a lot about current positioning. Short interest dropped sharply — falling 24% in two sessions on April 23-24 to 1.6% of the free float — as deal arbitrageurs unwound hedges following the green light. The ORTEX short score has also eased to 29.9 after sitting around 31.6 through most of April, consistent with shrinking short demand. Borrow availability is wide open, with cost to borrow running below 0.55% and no sign of stress in the lending market.
The analyst picture has been relatively quiet for months. Keefe, Bruyette & Woods upgraded STEL to Outperform with a $44 target back in early February — a significant move at the time, given that the stock was trading well below that level. The current mean target of $38 is roughly in line with the last close of $37.59, which makes sense for a deal-driven name where the merger terms set the effective ceiling. Piper Sandler has maintained a Neutral stance. The bull case centres on NIM expansion toward a 4% core target, strong deposit growth from new customers, and loan originations running at their highest level since 2022. Bears point to a modest NIM drift lower — core NIM slipped to 3.95% — and the ongoing drag from purchase accounting accretion running off.
Institutional ownership has been stable, with BlackRock holding 13.3% and Vanguard at 6.5%. North Reef Capital Management added over a million shares in Q4 2025, building to a 5.7% stake — the most active accumulation in the holder list. A cluster of insiders, including the CEO, CFO, President, and General Counsel, all sold small amounts in mid-March at $35.51, a routine-looking set of transactions at low significance scores.
The May 1 event now functions less as an earnings catalyst and more as a checkpoint on deal progress — the print tests whether management's NIM and loan growth narrative stays intact through the final stretch before the Prosperity acquisition closes.
See the live data behind this article on ORTEX.
Open STEL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
